cidr vaginaalravivahend
zoetis belgium - progesteroon - vaginaalravivahend - 1,38g 10tk
panadol pronto suukaudne suspensioon
glaxosmithkline consumer healthcare (uk) trading limited - paratsetamool - suukaudne suspensioon - 120mg 5ml 200ml 1tk; 120mg 5ml 100ml 1tk
nebido süstelahus
bayer ag - testosteroon - süstelahus - 250mg 1ml 4ml 1tk
falakef suukaudse suspensiooni pulber
nextmune italy s.r.l. - tsefaleksiin - suukaudse suspensiooni pulber - 50mg 1ml 100ml 1tk; 50mg 1ml 60ml 1tk
sedron õhukese polümeerikattega tablett
ideal trade links uab - alendroonhape - õhukese polümeerikattega tablett - 70mg 4tk
prevexxion rn
boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunoloogilised ained - kana - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).
prevexxion rn+hvt+ibd
boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kana - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.
voraxaze
serb sas - glucarpidase - metabolic side effects of drugs and substances - kõik muud ravitoimingud - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.
budesonide teva nebuliseeritav suspensioon
teva b.v. - budesoniid - nebuliseeritav suspensioon - 0,5mg 2ml 2ml 25tk; 0,5mg 2ml 2ml 10tk; 0,5mg 2ml 2ml 15tk; 0,5mg 2ml 2ml 20tk
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vaktsiinid - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.